Skip Navigation


Carcinogenesis Advance Access originally published online on June 24, 2004
Carcinogenesis 2004 25(10):1925-1934; doi:10.1093/carcin/bgh211
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
25/10/1925    most recent
bgh211v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Huang, W.-C.
Right arrow Articles by Chen, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, W.-C.
Right arrow Articles by Chen, C.-C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.25 no.10 © Oxford University Press 2004; all rights reserved.

ARTICLE

Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel {alpha}-methylene-{gamma}-butyrolactone derivatives

Wei-Chien Huang1, Shu-Ting Chan1, Tzu-Lin Yang1, Cherng-Chyi Tzeng2 and Ching-Chow Chen1,3

1 Department of Pharmacology, College of Medicine, National Taiwan University, Taipei 10018, Taiwan and 2 School of Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan

3 To whom correspondence should be addressed Email: ccchen{at}ha.mc.ntu.edu.tw

The transcription factor nuclear factor-kappaB (NF-{kappa}B) is a regulator related to cellular inflammation, immune responses and carcinogenesis. Therefore, components of the NF-{kappa}B-activating singnaling pathways are frequent targets for the anti-inflammatory and anticancer agents. In this study, CYL-19 s and CYL-26z, two synthetic {alpha}-methylene-{gamma}-butyrolactone derivatives, were shown to inhibit the tumor necrosis factor-alpha (TNF-{alpha})-induced intercellular adhesion molecule-1 (ICAM-1) expression in human A549 alveolar epithelial cells and the adhesion of U937 cells to these cells. RT–PCR analysis also demonstrated their inhibitory effects on TNF-{alpha}-induced ICAM-1 mRNA expression. TNF-{alpha}-induced ICAM-1 and NF-{kappa}B-dependent promoter activities were attenuated by CYL-19 s and CYL-26z. ICAM-1 promoter activities induced by the over-expression of wild-type NF-{kappa}B-inducing kinase and I{kappa}B kinase ß (IKKß) were also inhibited by both compounds. Furthermore, CYL-19 s and CYL-26z inhibited the TNF-{alpha}-induced phosphorylation and degradation of I{kappa}B{alpha} and NF-{kappa}B-specific DNA–protein binding activity via targeting IKK complex directly, without any effect on the activations of other kinases such as ERK1/2 and p38. In addition to ICAM-1 expression, CYL-19 s and CYL-26z also suppressed other NF-{kappa}B-mediated gene expressions such as matrix metalloproteinase-9 (MMP-9) mRNA and cyclooxygnease-2 (COX-2) protein. In Matrigel assays, ICAM-1 and COX-2 expressions induced by TNF-{alpha} elicited A549 and NCI-H292 cell invasion, respectively, and these effects were inhibited by both compounds. In summary, our data demonstrated that CYL-19 s and CYL-26z down-regulate the TNF-{alpha}-induced inflammatory genes expression through suppression of IKK activity and NF-{kappa}B activation. These agents may be effective in the anti-inflammatory and anticancer therapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
Y.-C. Lin, J.-H. Lin, C.-W. Chou, Y.-F. Chang, S.-H. Yeh, and C.-C. Chen
Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2
Cancer Res., April 1, 2008; 68(7): 2375 - 2383.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. O. Apostolov, S. V. Shah, E. Ok, and A. G. Basnakian
Carbamylated Low-Density Lipoprotein Induces Monocyte Adhesion to Endothelial Cells Through Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 826 - 832.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. K. Mukherjee, A. K. Mishra, S. Mukhopadhyay, and J. R. Hoidal
High Concentration of Antioxidants N-Acetylcysteine and Mitoquinone-Q Induces Intercellular Adhesion Molecule 1 and Oxidative Stress by Increasing Intracellular Glutathione
J. Immunol., February 1, 2007; 178(3): 1835 - 1844.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-C. Lin, C.-T. Shun, M.-S. Wu, and C.-C. Chen
A Novel Anticancer Effect of Thalidomide: Inhibition of Intercellular Adhesion Molecule-1-Mediated Cell Invasion and Metastasis through Suppression of Nuclear Factor-{kappa}B
Clin. Cancer Res., December 1, 2006; 12(23): 7165 - 7173.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-J. Chang, M.-S. Wu, J.-T. Lin, and C.-C. Chen
Helicobacter pylori-Induced Invasion and Angiogenesis of Gastric Cells Is Mediated by Cyclooxygenase-2 Induction through TLR2/TLR9 and Promoter Regulation
J. Immunol., December 15, 2005; 175(12): 8242 - 8252.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Moon, F. G. Bottone Jr., M. F. McEntee, and T. E. Eling
Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1
Mol. Cancer Ther., October 1, 2005; 4(10): 1551 - 1558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W.-C. Huang and C.-C. Chen
Akt Phosphorylation of p300 at Ser-1834 Is Essential for Its Histone Acetyltransferase and Transcriptional Activity
Mol. Cell. Biol., August 1, 2005; 25(15): 6592 - 6602.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Rosette, R. B. Roth, P. Oeth, A. Braun, S. Kammerer, J. Ekblom, and M. F. Denissenko
Role of ICAM1 in invasion of human breast cancer cells
Carcinogenesis, May 1, 2005; 26(5): 943 - 950.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.